Therapeutic Mechanisms of Glucocorticoids
- PMID: 29162310
- DOI: 10.1016/j.tem.2017.10.010
Therapeutic Mechanisms of Glucocorticoids
Abstract
Glucocorticoids (GCs) have been used clinically for decades as potent anti-inflammatory and immunosuppressive agents. Nevertheless, their use is severely hampered by the risk of developing side effects and the occurrence of glucocorticoid resistance (GCR). Therefore, efforts to understand the complex mechanisms underlying GC function and GCR are ongoing. The goal is to generate new glucocorticoid receptor (GR) ligands that can dissociate anti-inflammatory from metabolic side effects and/or overcome GCR. In this review paper we discuss recent insights into GR-mediated actions in GCR and novel therapeutic strategies for acute and chronic inflammatory diseases.
Keywords: glucocorticoid receptor; glucocorticoid resistance; inflammatory diseases; monomer–dimer concept; side effects.
Copyright © 2017 Elsevier Ltd. All rights reserved.
Similar articles
-
Dominance of the strongest: inflammatory cytokines versus glucocorticoids.Cytokine Growth Factor Rev. 2014 Feb;25(1):21-33. doi: 10.1016/j.cytogfr.2013.12.006. Epub 2013 Dec 24. Cytokine Growth Factor Rev. 2014. PMID: 24412262 Review.
-
New insights into the anti-inflammatory mechanisms of glucocorticoids: an emerging role for glucocorticoid-receptor-mediated transactivation.Endocrinology. 2013 Mar;154(3):993-1007. doi: 10.1210/en.2012-2045. Epub 2013 Feb 5. Endocrinology. 2013. PMID: 23384835 Review.
-
Targeting inflammation using selective glucocorticoid receptor modulators.Curr Opin Pharmacol. 2010 Aug;10(4):497-504. doi: 10.1016/j.coph.2010.04.007. Epub 2010 May 20. Curr Opin Pharmacol. 2010. PMID: 20493772 Review.
-
Non-genomic Effects of Glucocorticoids: An Updated View.Trends Pharmacol Sci. 2019 Jan;40(1):38-49. doi: 10.1016/j.tips.2018.11.002. Epub 2018 Nov 26. Trends Pharmacol Sci. 2019. PMID: 30497693 Free PMC article. Review.
-
An emphasis on molecular mechanisms of anti-inflammatory effects and glucocorticoid resistance.J Complement Integr Med. 2015 Mar;12(1):1-13. doi: 10.1515/jcim-2014-0051. J Complement Integr Med. 2015. PMID: 25503867 Review.
Cited by
-
FOXO1 Is a Key Mediator of Glucocorticoid-Induced Expression of Tristetraprolin in MDA-MB-231 Breast Cancer Cells.Int J Mol Sci. 2022 Nov 8;23(22):13673. doi: 10.3390/ijms232213673. Int J Mol Sci. 2022. PMID: 36430156 Free PMC article.
-
Skin Anti-Inflammatory Potential with Reduced Side Effects of Novel Glucocorticoid Receptor Agonists.Int J Mol Sci. 2023 Dec 23;25(1):267. doi: 10.3390/ijms25010267. Int J Mol Sci. 2023. PMID: 38203435 Free PMC article.
-
Managing Osteoporosis and Joint Damage in Patients with Rheumatoid Arthritis: An Overview.J Clin Med. 2021 Mar 17;10(6):1241. doi: 10.3390/jcm10061241. J Clin Med. 2021. PMID: 33802804 Free PMC article. Review.
-
Whole-orbit radiomics: machine learning-based multi- and fused- region radiomics signatures for intravenous glucocorticoid response prediction in thyroid eye disease.J Transl Med. 2024 Jan 13;22(1):56. doi: 10.1186/s12967-023-04792-2. J Transl Med. 2024. PMID: 38218934 Free PMC article.
-
Repression of the Glucocorticoid Receptor Aggravates Acute Ischemic Brain Injuries in Adult Mice.Int J Mol Sci. 2018 Aug 17;19(8):2428. doi: 10.3390/ijms19082428. Int J Mol Sci. 2018. PMID: 30126083 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
